Clinical Trial: Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: An Open-Label, Dose-Escalating Efficacy and Safety Study of Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy
Brief Summary: The purpose of this study is to determine if implitapide is effective in lowering triglyceride (TG) levels in patients with Fredrickson Type I or V hypertriglyceridemia where the maximum tolerable medication and diet were not sufficient.
Detailed Summary:
Sponsor: Medical Research Laboratories International
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Medical Research Laboratories International
Dates:
Date Received: March 23, 2004
Date Started: October 2004
Date Completion: April 2005
Last Updated: June 23, 2005
Last Verified: April 2005